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S_q A historical prospeti study was conducted at the Mercy Hospital of Pitsburgh, Pennsylvania
(USA), to study the rok of post-menopausal obesity in the recmue= and survival of brast cancer. Recods
from 301 post-menopusal women with breast cair fr 1977 to 1985 wer followed for at last 5
from data suppied by the Tumor Registry and medical records. Data col1ted i ded ae, heiht,
weight, race, reptor status, stag and sizx of tumour, number of postive nodes, site of distant
metastass, first course of teatment, and 5 year XecUr_es and survivaL Forty-five per cent of patiints were
obese (n = 136), while 55% wre non-obese (n = 165). Obesity was defined by the Quetelet index (patiets with
values >27 were considere obese). The re mre rates for the obese and non-obese groups wer40!/. and
39!r/1 l, and we not ntl di Univariate and mulVaate analyses showed that ther
was no sgnifant assolatin betwee obesity in post-menopausal women and lihdkehih of crrene of or
death from brast caino.
The adverse impact of excess body weight on general health
and longevity is clearly recognised. The Framingham Heart
Study, for example, is widely known for underscoring the
adverse effects of obesity on patients with cardiovascular
disease (Hubert et al., 1983). Another association, that
between obesity and increased risk of breast cancer, was first
pointed out by De Waard et al. (1964). Since then, numerous
studies in different parts of the world have either confirmed
the findings of De Waard et al. especialy with respect to
post-menopausal women (Valaoras et al., 1969; MacMahon
et al., 1970; Mirra et al., 1971; De Waard & Baanders-Van
Halewijn, 1974; Choi et al., 1978; Paffenbarger et al., 1980;
Lubin et al., 1985; Rose, 1986; Hershcopf & Bradlow, 1987;
Le Marchant et al., 1988; Negri et al., 1988; Tornberg et al.,
1988; Swanson et al., 1989; Ingram et al., 1989; Folsom et
al., 1990, Hsieh et al., 1990; Chu et al., 1991; Schapira et al.,
1991; den Tonkelaar et al., 1992), or reported results that
show no clear-cut relationships in either pre- or post-
menopausal women between breast cancer risk and obesity
(Ravnihar et al., 1971; Stavraky & Emmons, 1974; Adami et
al., 1977; Wynder et al., 1978).
Current statistics reveal that breast cancer is the second
leading cause of cancer mortality for women in the United
States (Boring et al., 1992). Epidemiological studies have
shown that obesity is associated with a poor prognosis of
survival from breast cancer (Donegan et al., 1978; Boyd et
al., 1981; Tartter et al., 1981; Zumoff & Dasgupta, 1983;
Greenberg et al., 1985; Newman et al., 1986; Hebert et al.,
1988; Mohle-Boetani et al., 1988; Kyogoku et al., 1990; Tretli
et al., 1990; Senie et al., 1992; Bastarrachea et al., 1994). Our
primary interest has been in studying the association of
obesity with recurre and survival from breast cancer in
post-menopausal women. Recognising that recurrence is a
significant factor contributing to survival outcome, we have
used multiple logistic regression to study recurrence and
survival in obese and non-obese post-menopausal women
adjusted for a number of other risk factors for breast cancer.
The results of our historical prospecitve study conducted in a
500-bed teaching hospital, in which obese and non-obese
post-menopausal women with breast cancer were compared
in terms of recurrence and survival during a minimum
foUlow-up period of 5 years, are reported.
Mateals and
Studypopulation
Data from 301 post-menopausal women diagnosed with
breast cancer from 1977 to 1985 were coletled. All 301
women were included as the cohort for this study. Oestrogen
(ER) and progesterone receptor (PR) analyses using the six-
point Scatchard plot method were performed on breast
cancer tissues in the Division of Nuclear Pathology and
Oncology of Mercy Hospital (where these analyses have been
ongoing since 1976). This database was used as the primary
source of our study populanon, and included the following
information on the study subjects: age, weight, height, ER
and PR values and the medical record number ofall patients
in the database.
Additional data were collected from the Tumor Registry
and medical records and inchlded the following date of
diagnois, marital status, family history of cancer, occupa-
tional history, menopausal status, race, diagnosis and coding
of tumour, stage and size of tumour, number of positive
nodes, site of distant metaasis, first course of treatment
(given within the first 4 months post diagnosis), additional
treatment (includes additional surgery, chemotherapy or
radiotherapy given 4 months after diagnosis) and 5 year
recurrence and survival (date of rcurrence or death and
contributing causes of death).
Recurrence and survival status were determined by review-
ing the Tumor Registry follow-up data and medical record
information. The Tumor Registry is accredited by the
American Colleg of Surgeons and uses active follow-up on
all cair patients. Recurrence was clasified into the follow-
ing categories: (1) never free of dises; (2) no recurrence; (3)
alive with reuArrence; (4) dead of disease due to recurrene;
(5) recurrece at time of any death. Survival status was
clas into the following categories: (1) alive; (2) death
from other causes; (3) dead from brast cancer.
Post-menopausal status was determined in patients oler
than 55. In patients younger than 55, determination was
made by consulting the Tumor Reity data, medical rrd
and physician records. Preenopausal patients and patients
menopausal status could not be determined from the
data source were excluded from the study. Obesity was
identified by using the Quetelet index (also called body mass
index, BMI), which is the weight divided by the height
squared, given in metric units: kgm-2. Values >27 were
considered to indicate obesity (Hopkins, 1989). Obesity was
determined at the date of diagnois. The effect of weight
changes during the follow-up period was not evaluated.
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Statistical analysis
Statistical analysis consisted of chi-square tests for discrete
variables and Student's t-tests for continuous variables. Odds
ratios and confidence intervals were constructed. Multiple
logistic regression was used to analyse recurrence and sur-
vival rates. All analyses were performed using BMDP.
Results were considered significant at a = 0.05. The appropri-
ateness of fit of the logistic regression model was evaluated
using the Hosmer-Lemeshow chi square statistic.
Results
The descriptive statistical data are summarised in Table I. Of
the 301 subjects, 69% (207/301) were alive at the end of the
follow-up period, while 31% (94/301) had died of breast
cancer. Twenty-eight other women who died of other causes
were not included in the analyses. The median age of the
study population was 72 years; 94% (283/301) were white
and only 6% (18/301) were black. Seventy-eight per cent
Table I Frequency distribution of study cohort
Variable Frequency (%
Survival
Alive
Dead (of breast cancer)
Age
<72
.72
Oestrogen receptor (ER) status
Positive
Negative
Unknown
Progesterone receptor (PR) status
Positive
Negative
Unknown
Level of treatment
Surgery
Surgery + therapy
Unknown
Obesitv
No
Recurrence
Yes
Recurrence
Recurrence
No
a No recurrence
b Never free of disease
Yes
a Alive with recurrence
b Dead of disease due to recurrence
c Recurrence at time of any death
Stage
I
11
111
IV
Unknown
Size of tumour
<2.0cm
.2.0cm
Unknown
Nodal status
0
1-3
4
Unknown
207 69
94 31
151 50
150 50
229
64
(8r
143 56
112 44
(46)b
181 62
112 38
(8Y
165
65
136
54
182
170
12
119
37
82
0
101
151
29
18
(2r
128 43
172 57
(Ir
166
66
54
(I5r
58
23
19
Race
White 283 94
Black 18 6
'Unknown figures were not included in the totals. b Samples for
ER-PR assays were not always sufficient to run both assays.
(229/293) of the study subjects were ER positive, while 22%
(64/293) were ER negative. For PR there were 56% (143/255)
positive and 44% (112/255) negative. Level of treatment was
separated into two categories: surgery and surgery plus other
therapy. Sixty-two per cent (181/293) received surgery alone
and 38% (112/293) received surgery plus either chemotherapy
or radiation therapy. The majority of the 301 subjects (55%,
165/301) were not obese (BMI <27), and 45% (136/301)
were obese. Recurrence of breast cancer was found in only
40% (119/301) of the subjects. Stages of breast cancer
included 34% (101/299) in stage I, 51% (151/299) in stage II,
10% (29/299) in stage III, and 6% (18/299) in stage IV.
Tumour size .2.0cm was found in 57% (172/300) of the
subjects, while 43% (128/300) had tumours <2.0cm. For
nodal status, 1-3 positive nodes were found in 23% (66/286)
of the subjects, .4 positive nodes were found in 19% (54/
286), while 58% (166/286) did not have positive nodes.
The univariate association between each variable and case
fatality is shown in Table II. For each variable the specific
associations analysed are indicated. For example, for age,
with women grouped into those who were .72 and those
who were <72, there was a significant difference in case
fatality reflected in the P-value of 0.007. However, the odds
ratio of 0.51 indicated that the relative risk of those .72
succumbing specifically to breast cancer was less than that of
women who were <72 years. This means that those indivi-
duals .72 years are living longer and could be dying of
causes other than breast cancer. Other contrasts that were
significant included ER negative vs ER positive; level of
treatment, which contrasted surgery plus other therapy with
surgery only; recurrence versus no recurrence; stage IV versus
stage I; size of tumour (.2.0cm vs <2.0cm); and nodal
status (1-3+ vs 0 and .4 vs 0). The relative risks were
consistent for these associations. Associations that lacked
significance consisted of PR, obesity, stage II vs I, stage III vs
I and race.
The results of a multivariate analysis for predicting death
from breast cancer are shown in Table III. In this analysis,
multiple logistic regression was used with case fatality as the
dependent variable and age, ER, PR, level of treatment,
obesity, recurrence, stages I-IV, size of tumour and nodal
status as the independent vanrables. Recurrence, stage IV, size
of tumour, and nodal status (1-3+ vs 0) emerged from this
analysis as significant predictors. All other variables, includ-
ing obesity, failed to show significance.
We next focused on recurrence as the dependent variable,
and conducted both univariate and multivariate analyses
with the same independent variables used in Tables II and
III. Table IV presents data on the univariate association
between each variable and recurrence. Level of treatment,
stage II vs I, size of tumour and nodal status (>4+ vs 0)
were determined to be significant. All other variables lacked
significant associations with recurrence.
Table V presents data on the multivariate analysis for
predicting recurrence. Level of treatment, stage III, size of
tumour and nodal status (>4+ vs 0) emerged with
P= <0.05, denoting significant associations for recurrence.
All other variables, again including obesity, failed to demon-
strate significant associations with recurrence for breast
cancer.
The cohort that was studied for this report had a median age
of 72 years. There were slightly more than twice the number
of patients who had survived the 5 year follow-up period
than who had died. The distribution of our hormone recep-
tor analyses confirmed what has been known for some time,
i.e. that in post-menopausal women the ER positives out-
number the ER negatives.
Although the positives predominate for PRs, the advant-
age is not as great as for the ERs. Our data showed 78% ER
positive and 22% ER negative, and 56% PR positive and
44% PR negative. This is consistent with the results of other930 A. KATOH et al.
similar analyses of hormone receptors in post-menopausal
women (Howell et al., 1984; Cooper et al., 1989; Shek &
Godolphin, 1989).
The univariate association between each variable and case
fatality (Table II) showed significant associations for age,
ER, level of treatment, recurrence, stage IV vs I, size of
tumour and nodal status. Other variables such as obesity
were not significant.
The analysis was taken to another level by considering a
multivariate analysis for predicting death from breast cancer
(by multiple logistic regression) while controlling for all of
the independent variables simultaneously. These data, shown
in Table III, emerged with recurrence, stage IV, size of
tumour and 1-3 positive nodes as significant factors for
predicting death from breast cancer. Other variables which
had been singled out in the univariate analysis (e.g. age, ER
status and level of treatment) were eliminated. Also, it is
noted that obesity, the variable of primary interest in this
study, showed no significance in either univariate or multi-
variate analyses. Race, which was heavily skewed toward the
white group, was not included in the multivariate analysis
because of the small numbers. However, it was interesting
that when the 18 black women in the study were examined,
12 (67%) were obese; of these 12, seven (58%) had recur-
rences. Coincidentally, the same numbers applied for death
from breast cancer. A separate study is in progress with the
aim of augmenting the numbers of African-American
women in our database.
The study continued to look at the same independent
variabls but changed the dependent variable to recurrence,
and the univariate and multivariate analyses are shown in
Tables IV and V. In the univanate analysis, level of treat-
ment, stage H vs I, size of tumour and >4 positive nodes
were the only variables showing significant associations with
recurrence. Sohrabi et al. (1980) in a retrospective study of
106 subjects undergoing mastectomy also found no associ-
ation between obesity and recurence. They noted as in our
study, however, that recurrence was related to tumour size
and nodal status. In contrast, Senie et al. (1992) reported on
a prospective study of consecutively treated patients for
primary breast cancer that obese women at diagnosis were at
significantly greater risk for recurre. Their study included
472 post-menopausal women; 123 (26%) of them were obese.
Tlhis contrasted with our population of 301 post-menopausal
Table H Uivanate assoation between each vanable and case fataitya
Variable Coefficient s.e. P-vahle Odds ratio 95% CI
Age -0.680 0.254 0.007 0.51 [0.31, 0.83]
;¢72 vs <72
ER 0.720 0.294 0.014 2.06 [1.15, 3.66]
Negative vs positive
PR 0.354 0.273 0.194 1.42 [0.83, 2.43]
Negative vs positive
Level of treatnent 1.96 0.284 0.001 7.13 [4.08, 12.45]
Surgery + therapy vs surgery
Obesity -0.157 0.249 0.527 0.85 [0.52, 1.39]
Yes vs no
Recurrence 3.45 0.358 0.001 31.4 [15.5, 63.6]
Yes vs no
Stage
II vs I 0.127 0.249 0.510 1.14 [0.70, 1.85]
In vs I 0.337 0.404 0.404 1.40 [0.63, 3.10]
IV vs I 2.56 0.646 0.001 13.01 [3.7, 46.2]
Size of twnour 1.14 0.277 0.001 3.13 [1.82, 5.40]
;¢2.0cm vs <2.0cm
Nodal status
1-3+vs 0 0.81 0.33 0.01 2.27 [1.19, 4.33]
4 vs 0 1.73 0.34 0.000 5.67 [2.91, 11.04]
Race 0.857 0.814 0.292 2.36 [0.48, 11.64]
Black vs white
'Derived using logistic regression analysis.
Tabe HI Multivariate analysis for predicting case fatalitya
Variable Coefficient s.e. P-vahle Odds ratio 95% CI
Age -0.754 0.4% 0.129 0.47 [0.18, 1.24]
ER 0.226 0.628 0.719 1.25 [0.37, 4.30]
PR 0.031 0.515 0.953 1.03 [0.38, 2.83]
Lewel of treatnnent 0.540 0.472 0.252 1.72 [0.68, 4.33]
Obesity -0.006 0.455 0.988 0.99 [0.41, 2.42]
Recurrence 5.07 0.849 0.000 159.8 [30.3, >100]
Stage
I1 -0.826 0.703 0.240 0.44 [0.11, 1.74]
III -0.033 1.25 0.979 0.97 [0.08, 11.30]
IV 4.91 1.49 0.001 135.7 [7.2, >100]
Size of tunour 1.09 0.566 0.054 2.97 [0.98, 9.03]
Nodal status
1-3 + vs 0 1.35 0.70 0.05 3.85 [0.97, 15.27]
B4 + vs 0 1.23 0.73 0.09 3.43 [0.82, 14.27]
Note: Race was not used in this model because of the small sample size for black women
(n = 18). 'Derived using multiple logistic regression analysis. The appropnateness of fit of the
model was evaluated using the Hosmer-Lemeshow chi-squae statistic.OBESITY AND BREAST CANCER 931
Table IV Univariate association between each variable and recurrence
Variable Coefficient s.e. P-value Odds ratio 95% CI
Age -0.017 0.236 0.94 0.98 [0.62, 1 56
>72 vs <72
ER 0.320 0.286 0.26 1.38 [0.79, 2.41]
Negative vs positive
PR 0.248 0.257 0.33 1.28 [0.77, 2.12]
Negative vs positive
Level of treatment 1.824 0.265 0.001 6.19 [3.68, 10.41]
Surgery + Therapy vs Surgry
Obesity -0.013 0.237 0.96 0.99 [0.62, 1.57]
Yes vs no
Stage
II vs 1 0.569 0.269 0.03 1.77 [1.04, 2.99]
111 vs 1 0.276 0.438 0.53 1.32 [0.56, 3.11]
IV vs I 0.545 0.520 0.29 1.72 [0.62, 4.78]
Size of twnour 0.807 0.248 0.001 2.24 [1.38, 3.64]
2.0 vs <2.0cm
Nodal status
1-3 + vs 0 0.32 0.30 0.29 1.37 [0.76. 2.50]
,4+ vs 0 1.26 0.33 0.001 3.54 [1.87, 6.71]
Race 0.691 0.490 0.158 2.00 [0.76, 5.21]
Black vs white
'Derived using logistic regression analysis.
Tabe V Multivariate analysis for predicting recurrence
Variable Coefficient s.e. P-value Odds ratio 95% CI
Age 0.445 0.325 0.171 1.56 [0.83, 2.95]
ER 0.402 0.443 0.364 1.50 [0.63, 3.56]
PR 0.532 0.373 0.153 1.70 [0.82, 3.54]
Level of treatment 2.147 0.352 0.000 8.56 [4,29, 17.08]
Obesity 0.314 0.318 0.325 1.37 [0.73, 2.56]
Stage
II -0.511 0.469 0.277 0.60 [0.24, 1.51]
III -2.195 0.749 0.003 0.11 [0.03, 0.48]
IV -1.776 1.048 0.090 0.17 [0.02, 1.32]
Size of twnour 0.800 0.379 0.035 2.23 [1.06, 4.69]
Nodal status
1-3 + vs 0 0.788 0.457 0.86 1.08 [0.44, 2.65]
,4+ vs 0 1.189 0.4% 0.017 3.29 [1.24, 8.70]
Note: Race was not used in this model because of the small sample size for black women
(n = 18). 'Derived using multiple logistic regression. The appropriateness offit of the model was
evaluated using the Hosmer-Lemeshow chi-square statistic.
women, among whom 136 (45%) were obese. Obesity was
the only significnt prognostic factor g from multi-
variate analysis that controlled for tumour size, number of
positive nodes, age at diagnosis and adjuvant chemotherapy
with a hazard ratio of 1.29 (Senie et at., 1992). This contrasts
with our data, which by multivariate analysis showed that
level of treatment, stage I, size of tumour and >4 positive
nodes but not obesity, were significantly associated with
recurrence (Table V). In a more recent study by Bastarrachea
et al. (1994), an association was found by multivariate
analysis for breast cancer recurrence (relative risk of 1.33)
among obese patients. This was studied in 735 consecutive
patients with primary breast cancer who had undergone
surgery with subsequent adjuvant chemotherapy. Of interest
here was the persistence of the prognostic effect of obesity
even with adjuvant chemotherapy.
Another recent study (Daniell et al., 1993) showed that
obesity and smoking are related to larger lymph node meta-
stases. This was explained by a more rapid growth of meta-
static tissues in both obese women and smokers, coupled
with an earlier onset of metastasis from their primary breast
cancers. The development of earlier and larger metastases in
obese women could be attributed to impaired immunity
(Chandra & Kutty, 1980). Impairment of immune responses
in obese women is known, for example, in their weaker
response to hepatitis B vaccination (Weber et al., 1985,
1987). Adipocytes with enhanced angiogenic potential could
also be a factor in early cancer metastasis in obese women
(Castellot et al., 1980).
Ever since De Waard et al. (1964) pointed out the relation-
ship between obesity and the risk for breast cancer, many
investigators have reported a positive relationship between
obesity and decreased survival from breast cancer. Dis-
crepancies have been noted in that some studies have re-
ported this relationship for all breast cancer stages (Tartter et
al., 1981; Newman et al., 1986; Kyogoku et al., 1990). Others
have found obesity and poorer survival only in the early
stages of breast cancer (Donegan et al., 1978; Boyd et al.,
1981; Hebert et al., 1988; Tretli et al., 1990), while Greenberg
et al. (1985) found a significant trend towards lower survival
with increasng weight in premenopausal breast cancer
patients. In contrast to these reports. Ewertz et al. (1991)
found an increased risk of dying from breast cancer
associated with low body weight. However, this was in sub-
jects with stage IV or advanced breast cancer.
The overall results of this study showed that no significant
association could be demonstrated between obesity (using the
Quetelet index) and recurrence or death from breast cancer.932 A. KATOH et al.
Even when the BMI was divided into quintiles (data not
shown), no significant associations with recurrence were
detected. Recurrence itself, however, was recognised as a
significant predictor for case fatality along with stage IV
disease, large tumour and the presence of positive nodes. The
last three variables have long been associated by clinicians
with a poor prognosis for breast cancer (Perez et al., 1992)
and have indeed been associated with case fatality in this
study. Also, variables such as level of treatment, stage, size of
tumour and positive nodes were predictors for recurrence.
Because it was suspected that the level of treatment may be
correlated with other independent variables, it was removed
and reanalysed using multivariate analysis. All other prog-
nostic factors remained the same, except for nodal status, in
which the P-values were slightly reduced. It was not possible
in this study to detect a relative risk of 1.5-2.0. In order to
detect a relative risk of this magnitude, we would have
required a sample at least three times larger. Tretli et al.
(1990), in a study of more than 8,000 women, found a
prognostic effect of obesity on the death rate from breast
cancer in both pre- and post-menopausal women. A similar
finding was reported by Mohle-Boetani et al. (1988). In spite
of the large sample size available to Tretli et al. (1990),
overweight was not a prognostic factor for survival in all
breast cancer patients, i.e. not for stages III and IV. Hence.
we believe the sample size in our study is adequate to sup-
port the conclusion that no clinically relevant association
could be demonstrated between obesity and chance of death
from or recurrence of breast cancer in post-menopausal
women.
Many studies have now been reported on various facets of
the suspected link between overweight and fatality from
breast cancer. Some have even suggested embarking on a
dietary intervention trial as a means of increasing the disease-
free survival period (Wynder & Cohen, 1982; Wynder et al..
1990; Chlebowski et al., 1991; Cohen et al., 1993). The
conclusive establishment of a significant association between
obesity and decreased survival in post-menopausal women,
however, remains elusive. A point made by Adami et al.
(1977) may be pertinent. Their study found no increase in
breast cancer risk in both pre- and post-menopausal women
among 179 consecutive, unselected breast cancer patients and
age-matched controls selected from a computerised popula-
tion register. This was conducted in Sweden, a high-risk
country for breast cancer. Adami et al. (1977) stress the
importance of their control group, which was chosen from
the whole female population in each county and which made
exact age matching possible. The patient and control groups
consisted of a homogeneous Caucasian population which was
unselected with respect to marital status, socioeconomic
status, place of residence, parity. age or stage of disease.
They point out that other published studies performed on
hospital patients are composed of a very heterogeneous
group. This practice can be hazardous for epidemiological
studies. What biases are introduced by hospital patients may
be difficult to monitor and ascertain. The ethnic homogeneity
in the study by Adami et al. (1977) is another factor that is
not matched in most other studies. We submit that these
issues may be contributing to the discordant results reported
for the role of obesity on survival from breast cancer by
various investigators in different parts of the world.
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